Chemomab Therapeutics Ltd. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Chemomab Therapeutics Ltd. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.01 USD/shares, a 55.6% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Earnings Per Share, Basic for 2023 was 0.1 USD/shares, a 16.5% decline from 2022.
  • Chemomab Therapeutics Ltd. annual Earnings Per Share, Basic for 2022 was 0.12 USD/shares, a 100% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0.01 $0 -55.6% Apr 1, 2024 Jun 30, 2024 6-K 2024-08-21
Q2 2023 $0.15 $0.04 +$0.01 +37% Apr 1, 2023 Jun 30, 2023 6-K 2024-08-21
Q1 2023 $0.14 $0.04 +$0.02 +90.9% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $0.12 $0.04 Oct 1, 2022 Dec 31, 2022 20-F 2024-03-28
Q3 2022 $0.04 +$0.02 +154% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $0.03 +$0.01 +76.9% Apr 1, 2022 Jun 30, 2022 6-K 2023-08-14
Q1 2022 $0.02 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $0.01 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0.01 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.